Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 Jan-Mar;31(1):1-8.
doi: 10.4103/jfcm.jfcm_236_23. Epub 2024 Jan 8.

Serotonin syndrome: An often-neglected medical emergency

Affiliations
Review

Serotonin syndrome: An often-neglected medical emergency

Ahmed Badar. J Family Community Med. 2024 Jan-Mar.

Abstract

Optimum serotonin level in the serotonergic synapses of the central nervous system (CNS) is related to mood, behavior, and sleep. Serotonin syndrome (SS) is a rare yet very dangerous adverse effect resulting from increased serotonin in CNS. The diagnosis of SS is based on the presence of clinical symptoms, which can include agitation, confusion, rapid heart rate, high blood pressure, dilated pupils, muscle rigidity, tremors, sweating, and diarrhea. SS is invariably caused by inadvertent use of serotonergic medicines. There is an ever-growing list of medicines that are associated with the risk of SS. Some of the common classes of drugs that can contribute to the development of SS include selective serotonin reuptake inhibitors, serotonin-norepinephrine reuptake inhibitors, monoamine oxidase inhibitors, tricyclic antidepressants, stimulants (e.g., amphetamines and cocaine), lithium, opioids, drugs used for recreational purposes like ecstasy Methylenedioxymethamphetamine (MDMA), and some herbal supplements (e.g., St. John's Wort). SS can occur when these medications are taken alone or in combination, especially when a new medication is added, or the dose of an existing medication is changed. The management of SS typically involves discontinuing the use of the substance that caused the excess serotonin levels and providing supportive care, such as intravenous fluids and electrolytes. In severe cases, benzodiazepines may be used to control agitation and muscle rigidity, while serotonin antagonists, such as cyproheptadine, may be used to reduce serotonin levels. The literature review points to a general unawareness among physicians about the condition or drugs associated with it. Consequently, this potentially fatal condition is overlooked. There is a need for regular information updates and reminders to all those who prescribe medications to the patients.

Keywords: Selective serotonin reuptake inhibitors; serotonin; serotonin syndrome.

PubMed Disclaimer

Conflict of interest statement

There are no conflicts of interest.

Figures

Figure 1
Figure 1
Conditions mimicking serotonin syndrome
Figure 2
Figure 2
Hunter’s criteria for diagnosis of serotonin syndrome

References

    1. Mitro P, Hijova E, Mudrakova K. Role of the peripheral serotoninergic system in the pathogenesis of vasovagal syncope. Bratisl Lek Listy. 2006;107:248–52. - PubMed
    1. Berger M, Gray JA, Roth BL. The expanded biology of serotonin. Annu Rev Med. 2009;60:355–66. - PMC - PubMed
    1. Nichols DE, Nichols CD. Serotonin receptors. Chem Rev. 2008;108:1614–41. - PubMed
    1. Wright P, O’Neill MF. Chapter-39 – Psychopharmacology. In: Wright P, Stern J, Phelan M, editors. Core Psychiatry. 3rd. Philadelphia: W. B. Saunders; 2012. pp. 585–615.
    1. Simon LV, Keenaghan M. StatPearls. Treasure Island (FL): StatPearls Publishing; 2023. Serotonin syndrome. Available from: https://www.ncbi.nlm.nih.gov/books/NBK482377/ [Last updated on 2023 Jul 17] - PubMed